Results for tag: "Motor Neurone Disease Drug"

Motor Neurone Disease (MND) is a progressive neurological disorder that affects the nerves in the brain and spinal cord. It is a debilitating and ultimately fatal condition, with no known cure. As such, the focus of treatment is on managing symptoms and slowing the progression of the disease. The Motor Neurone Disease Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat a range of neurological conditions. These drugs are typically used to reduce symptoms, improve quality of life, and slow the progression of the disease. Commonly prescribed drugs for MND include riluzole, edaravone, and nusinersen. The Motor Neurone Disease Drug market is highly competitive, with a number of large pharmaceutical companies vying for market share. Some of the major players in the market include Biogen, Novartis, Sanofi, and Roche. Show Less Read more